Three dimensional transesophageal echocardiography: a missing link in infective endocarditis imaging?
Infective endocarditis
Three dimensional transesophageal echocardiography
Two dimensional transesophageal echocardiography
Journal
The international journal of cardiovascular imaging
ISSN: 1875-8312
Titre abrégé: Int J Cardiovasc Imaging
Pays: United States
ID NLM: 100969716
Informations de publication
Date de publication:
Mar 2020
Mar 2020
Historique:
received:
28
07
2019
accepted:
09
12
2019
pubmed:
7
1
2020
medline:
23
6
2020
entrez:
6
1
2020
Statut:
ppublish
Résumé
The role of two dimensional (2D) echocardiography (ECHO) for the diagnosis and clinical decision making in infective endocarditis (IE) has been extensively studied and described in the medical literature. Some reports have demonstrated the incremental value of three dimensional (3D) transesophageal (TE) ECHO in the setting of IE. However, a systematic review focusing on the role of 3D imaging is lacking. In this manuscript, we examine the role of 3D TE ECHO in the diagnosis of IE. IE is a challenging disease in which 2D transthoracic (TT) and TE ECHO have complementary roles and are unequivocally the mainstay of diagnostic imaging. Still, 2D imaging has important limitations. Technological advances in 3D imaging allow for the reconstruction of real-time anatomical images of cardiac structure and function. 3D imaging has emerged as a diagnostic technique that overcame some of the limitations of 2D ECHO. Currently, both transthoracic and transesophageal echocardiography transducers are able to generate 3D images. However, 3D TE ECHO provides images of a higher quality in comparison to 3D TT ECHO, and is the best echocardiographic modality able to allow for a detailed anatomical imaging. 3D TE ECHO may represent the key adjunctive echocardiographic technique being able to positively impact on IE-related surgical planning and intervention and to facilitate the interaction between the surgeon and the imaging specialist. Importantly, 3D TE ECHO is not the recommended initial modality of choice for the diagnosis of IE; however, in highly specialized centers, it has become an important complementary technique when advanced surgical planning is required. Furthermore, anatomical imaging has become the link between the different techniques that play a role in IE imaging. In fact, both computed tomography and magnetic resonance allow three dimensional reconstruction. An important future goal should allow for the fusion among various imaging modalities. Our review highlights the role of 3D TE ECHO in IE imaging and emphasize where it offers incremental value.
Identifiants
pubmed: 31902093
doi: 10.1007/s10554-019-01747-x
pii: 10.1007/s10554-019-01747-x
doi:
Types de publication
Journal Article
Systematic Review
Video-Audio Media
Langues
eng
Sous-ensembles de citation
IM
Pagination
403-413Références
Eur J Echocardiogr. 2010 Apr;11(3):E7
pubmed: 19995799
J Am Soc Echocardiogr. 2010 Oct;23(10):1009-18; quiz 1112
pubmed: 20868952
Circulation. 1994 Jun;89(6):2684-7
pubmed: 8205682
Echocardiography. 2017 Jan;34(1):143-144
pubmed: 27550778
Eur Heart J. 2009 Oct;30(19):2369-413
pubmed: 19713420
Circ Cardiovasc Imaging. 2014 Jan;7(1):149-54
pubmed: 24214886
J Am Coll Cardiol. 2011 Aug 30;58(10):1001-6
pubmed: 21867833
J Am Soc Echocardiogr. 2017 Jul;30(7):639-646.e8
pubmed: 28483353
Neth Heart J. 2016 Feb;24(2):96-107
pubmed: 26744343
Am J Cardiol. 1999 Jul 1;84(1):110-3, A9
pubmed: 10404866
Echocardiography. 2015 Mar;32(3):607-9
pubmed: 25323487
Clin Cardiol. 2009 Dec;32(12):E55-62
pubmed: 20014188
Europace. 2013 Jan;15(1):89-100
pubmed: 22968846
Am J Cardiol. 2006 Nov 1;98(9):1261-8
pubmed: 17056343
J Cardiovasc Echogr. 2019 Jan-Mar;29(1):14-16
pubmed: 31008032
Echocardiography. 2009 Nov;26(10):1264-73
pubmed: 19929872
Cardiovasc Ultrasound. 2005 Sep 19;3:30
pubmed: 16171516
Clin Infect Dis. 2000 May;30(5):825-6
pubmed: 10816155
Clin Infect Dis. 2000 Apr;30(4):633-8
pubmed: 10770721
Curr Anesthesiol Rep. 2017;7(3):291-298
pubmed: 28890667
Echocardiography. 2014 Sep;31(8):E250-3
pubmed: 25039665
Eur Heart J Cardiovasc Imaging. 2012 Jan;13(1):1-46
pubmed: 22275509
J Am Coll Cardiol. 2017 Jan 24;69(3):325-344
pubmed: 28104075
Curr Cardiol Rep. 2017 Oct 25;19(12):127
pubmed: 29071426
Echocardiography. 2009 Sep;26(8):980-7
pubmed: 19968687
Am Heart J. 2007 Nov;154(5):923-8
pubmed: 17967599
Echocardiography. 2017 Apr;34(4):549-556
pubmed: 28213933
Eur J Echocardiogr. 2010 Dec;11(10):E37
pubmed: 20667849
Echocardiography. 2014 Feb;31(2):188-96
pubmed: 23937618
Am J Cardiol. 2011 Jan;107(1):100-2
pubmed: 21146695
J Am Soc Echocardiogr. 2007 Nov;20(11):1314.e9-11
pubmed: 17630248
J Am Soc Echocardiogr. 2014 May;27(5):453-62
pubmed: 24637057
Eur Radiol. 2015 Jul;25(7):2125-33
pubmed: 25680715
Circulation. 2011 Apr 12;123(14):e400-2
pubmed: 21482969
Echocardiography. 2014;31(1):E24-6
pubmed: 24117974
Echocardiography. 2014 Nov;31(10):1293-309
pubmed: 25257956
J Am Coll Cardiol. 2019 Aug 27;74(8):1031-1040
pubmed: 31439211
J Am Soc Echocardiogr. 2009 Apr;22(4):435.e1-3
pubmed: 19201573
Hellenic J Cardiol. 2013 Mar-Apr;54(2):147-9
pubmed: 23557617
Infection. 2016 Dec;44(6):725-731
pubmed: 27189337
Tex Heart Inst J. 2015 Aug 01;42(4):372-6
pubmed: 26413022
J Cardiol. 1998;31 Suppl 1:19-33; discussion 34-6
pubmed: 9666395
Tex Heart Inst J. 2016 Aug 01;43(4):345-9
pubmed: 27547149